Drug intelligence / Profile preview

Ketraline

Development stage
Unknown
Lead developer
Jiangxi Hengkang Pharmaceutical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral
01

Overview

Ketraline (also known as Keteling) is an approved oral combination therapy developed and manufactured by Jiangxi Hengkang Pharmaceutical for the treatment of cough, asthma, and chronic bronchitis. It is formulated as tablets containing a combination of Ficus microcarpa dry extract (a traditional Chinese herbal medicine) and chlorpheniramine maleate (a synthetic antihistamine). Ficus microcarpa dry extract provides antitussive, expectorant, and anti-inflammatory effects, while chlorpheniramine maleate acts as a histamine H1 receptor antagonist to alleviate allergic symptoms and reduce airway secretions. Together, these components work synergistically to relieve cough and respiratory discomfort.

Brand names
Ketraline
Other names
KetelingKeteling tabletsKetraline Tablets咳特灵咳特灵片
02

Targets

HRH1 (Histamine H1 Receptor)

Beyond the preview

Go deeper on Ketraline.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ketraline.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call